𝔖 Bobbio Scriptorium

✦ LIBER ✦

Pharmacological Synergy, Multi-Target Therapeutics - the Past and the Future in Headache Therapy?

✍ Scribed by Blumenfeld, Andrew; Cady, Roger

Book ID: 119855021
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 29 KB
Volume: 52
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2012.02283.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological Synergy, Multi-Target Th

Pharmacological Synergy, Multi-Target Therapeutics - The Past and the Future in Headache Therapy?

✍ Haag, Gunther 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

The Future of Osteoarthritis Therapeutic

The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy

✍ Mobasheri, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 333 KB

Pharmacological methods in the past, pre

Pharmacological methods in the past, present and future

✍ Michael J. Curtis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Pharmacology in The Netherlands: past, p

Pharmacology in The Netherlands: past, present and future

✍ Jan M. van Ree; Douwe D. Breimer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 700 KB

The past and future of CD33 as therapeut

The past and future of CD33 as therapeutic target in acute myeloid leukemia

✍ Laszlo, George S.; Estey, Elihu H.; Walter, Roland B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Experimental Therapeutics in Hereditary

Experimental Therapeutics in Hereditary Neuropathies: The Past, the Present, and the Future

✍ David N. Herrmann 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 100 KB

Hereditary neuropathies represent approximately 40% of undiagnosed neuropathies in a tertiary clinic setting. The Charcot-Marie-Tooth neuropathies (CMT) are the most common. Mutations in more than 40 genes have been identified to date in CMT. Approximately 50% of CMT cases are accounted for by CMT t